Evidence map›Paper›PMID 41397967›Full record

ArticleCell death discovery2025

The chaperone GRP94 interacts with the proprotein convertase furin and regulates TGF-beta maturation in human primary M2 macrophages.

Valentin Baverel, Fangmin Wang, Carmen Garrido, Evelyne Kohli

Abstract read
In one paragraph

Article in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Valentin BaverelUniversité Bourgogne Europe, UFR des Sciences de Santé, Dijon, France.ORCID http://orcid.org/0000-0001-7214-0983
Fangmin WangUniversité Bourgogne Europe, UFR des Sciences de Santé, Dijon, France.
Carmen GarridoUniversité Bourgogne Europe, UFR des Sciences de Santé, Dijon, France.
Evelyne KohliUniversité Bourgogne Europe, UFR des Sciences de Santé, Dijon, France. evelyne.kohli@u-bourgogne.fr.ORCID http://orcid.org/0000-0002-9383-6573

Funding

Institut National Du Cancer (French National Cancer Institute) PLBIO21-107Institut National Du Cancer (French National Cancer Institute) PLBIO-22-093Ligue Contre le Cancer EL2023 LNCC/CaG/
6 · The paper itself

Abstract

Transforming growth factor-beta (TGFβ) is a major immunosuppressive cytokine produced by various cell types, including regulatory T cells (Tregs) and M2 macrophages. In Tregs, GRP94 is known as a key protein regulating TGFβ expression by chaperoning both the TGFβ docking receptor, GARP, and the integrin αvβ8. We previously reported that GRP94 inhibition in a triple-negative breast cancer (TNBC) murine model induced a decrease in intra-tumoral CD206 + M2-like macrophages that correlated with a decrease in collagen content, an increase in CD8+ cells in tumors and a reduced tumor volume. Here, we investigated the impact of GRP94 inhibition on TGFβ expression focusing on a possible interaction with furin, a proprotein convertase responsible for the first step in TGFβ maturation. We demonstrated in human primary M2 macrophages that GRP94 interacted with furin and that GRP94 inhibition by its selective inhibitor PU-WS13 led to a decrease in furin enzymatic activity, which was associated with a decrease in TGFβ secretion. Similar results were obtained in the human TNBC cell line MDA-MB-231 using PU-WS13 and GRP94 inhibitor- 1, suggesting that our findings are not cell type-specific. Finally, we showed that GRP94 associated with LRRC33, a GARP paralog in macrophages. Together, these findings support the hypothesis that GRP94 plays a key role in regulating the TGFβ maturation pathway, not only in Tregs as previously reported, but also in M2 macrophages and tumor cells.

Identifiers

PMID41397967
PMCPMC12706012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.